CCR9 and prostate cancer: CCL25 and its receptor C-C motif chemokine receptor 9 (CCR9) are overexpressed in cancers such as leukemia, ovarian cancer, breast cancer, prostate cancer, liver cancer, lung cancer, and melanoma [36].